Interestingly, resistance may be overcome by ABCB1 inhibitors (verapamil and elacridar), which can be used against drug resistance mediated by ABCB1, in ovarian cancer treated by olaparib and paclitaxel (Vaidyanathan et al., 2016). The gene discussed is ABCB1; the disease is ovarian carcinoma.